Home › Pulmonary Fibrosis › Texas
Pulmonary Fibrosis clinical trials in Texas
3 studies for Pulmonary Fibrosis are looking for participants at sites in Texas.
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Premier Pulmonary Critical Care and Sleep Medicine, Denison
- Renovatio Clinical, The Woodlands
- Renovatio Clinical, Webster
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07284602Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- and 2 more
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.